3-195867623-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001382273.1(TNK2):​c.2675G>A​(p.Arg892His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0172 in 1,599,384 control chromosomes in the GnomAD database, including 294 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R892C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 15 hom., cov: 32)
Exomes 𝑓: 0.018 ( 279 hom. )

Consequence

TNK2
NM_001382273.1 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1B:3

Conservation

PhyloP100: 0.806

Publications

15 publications found
Variant links:
Genes affected
TNK2 (HGNC:19297): (tyrosine kinase non receptor 2) This gene encodes a tyrosine kinase that binds Cdc42Hs in its GTP-bound form and inhibits both the intrinsic and GTPase-activating protein (GAP)-stimulated GTPase activity of Cdc42Hs. This binding is mediated by a unique sequence of 47 amino acids C-terminal to an SH3 domain. The protein may be involved in a regulatory mechanism that sustains the GTP-bound active form of Cdc42Hs and which is directly linked to a tyrosine phosphorylation signal transduction pathway. Several alternatively spliced transcript variants have been identified from this gene, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Jul 2008]
TNK2 Gene-Disease associations (from GenCC):
  • infantile-onset mesial temporal lobe epilepsy with severe cognitive regression
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003913641).
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0116 (1762/152204) while in subpopulation EAS AF = 0.0256 (132/5162). AF 95% confidence interval is 0.022. There are 15 homozygotes in GnomAd4. There are 812 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNK2NM_001382273.1 linkc.2675G>A p.Arg892His missense_variant Exon 13 of 16 ENST00000672887.2 NP_001369202.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNK2ENST00000672887.2 linkc.2675G>A p.Arg892His missense_variant Exon 13 of 16 NM_001382273.1 ENSP00000499899.1

Frequencies

GnomAD3 genomes
AF:
0.0116
AC:
1765
AN:
152086
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00287
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.00916
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.0257
Gnomad SAS
AF:
0.0155
Gnomad FIN
AF:
0.00556
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0173
Gnomad OTH
AF:
0.00908
GnomAD2 exomes
AF:
0.0139
AC:
3239
AN:
232512
AF XY:
0.0144
show subpopulations
Gnomad AFR exome
AF:
0.00318
Gnomad AMR exome
AF:
0.00383
Gnomad ASJ exome
AF:
0.00628
Gnomad EAS exome
AF:
0.0259
Gnomad FIN exome
AF:
0.00769
Gnomad NFE exome
AF:
0.0174
Gnomad OTH exome
AF:
0.0138
GnomAD4 exome
AF:
0.0178
AC:
25818
AN:
1447180
Hom.:
279
Cov.:
52
AF XY:
0.0176
AC XY:
12669
AN XY:
720216
show subpopulations
African (AFR)
AF:
0.00290
AC:
97
AN:
33440
American (AMR)
AF:
0.00460
AC:
205
AN:
44550
Ashkenazi Jewish (ASJ)
AF:
0.00615
AC:
160
AN:
26010
East Asian (EAS)
AF:
0.0310
AC:
1228
AN:
39676
South Asian (SAS)
AF:
0.0168
AC:
1450
AN:
86120
European-Finnish (FIN)
AF:
0.00881
AC:
354
AN:
40190
Middle Eastern (MID)
AF:
0.0122
AC:
70
AN:
5718
European-Non Finnish (NFE)
AF:
0.0192
AC:
21290
AN:
1111256
Other (OTH)
AF:
0.0160
AC:
964
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1607
3214
4820
6427
8034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0116
AC:
1762
AN:
152204
Hom.:
15
Cov.:
32
AF XY:
0.0109
AC XY:
812
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00287
AC:
119
AN:
41524
American (AMR)
AF:
0.00915
AC:
140
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3470
East Asian (EAS)
AF:
0.0256
AC:
132
AN:
5162
South Asian (SAS)
AF:
0.0151
AC:
73
AN:
4826
European-Finnish (FIN)
AF:
0.00556
AC:
59
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0173
AC:
1176
AN:
67986
Other (OTH)
AF:
0.00899
AC:
19
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
89
178
266
355
444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0154
Hom.:
65
Bravo
AF:
0.0116
TwinsUK
AF:
0.0197
AC:
73
ALSPAC
AF:
0.0166
AC:
64
ESP6500AA
AF:
0.00273
AC:
12
ESP6500EA
AF:
0.0175
AC:
150
ExAC
AF:
0.0143
AC:
1728
Asia WGS
AF:
0.0120
AC:
43
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TNK2: BP4, BS1, BS2 -

Jan 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Parkinson disease Pathogenic:1
Jan 01, 2016
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T;.;T;T
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.81
.;T;T;T
MetaRNN
Benign
0.0039
T;T;T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
1.8
.;.;L;.
PhyloP100
0.81
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-2.7
D;N;N;N
REVEL
Benign
0.068
Sift
Uncertain
0.023
D;D;D;D
Sift4G
Uncertain
0.011
D;T;T;T
Polyphen
0.0010, 0.81, 0.43
.;B;P;B
Vest4
0.32, 0.23, 0.29
MPC
0.0061
ClinPred
0.023
T
GERP RS
0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.029
gMVP
0.30
Mutation Taster
=100/0
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112384084; hg19: chr3-195594494; COSMIC: COSV57369804; COSMIC: COSV57369804; API